PRECLINICAL CHARACTERIZATION OF A NOVEL CLASS OF HIGHLY POTENT SMALL MOLECULE HEPATITIS B AND D VIRUS ENTRY INHIBITORS

被引：0
|
作者：
Contreras, Heidi [1 ]
Azimova, Dinara [1 ]
Tan, Joseph [1 ]
Unchwaniwala, Nuruddin [1 ]
Guo, Lida [1 ]
Shen, Michael [1 ]
Yu, Jiaxin [1 ]
Windisch, Marc P. [1 ]
Xu, Xiang [1 ]
Perron, Michel [1 ,2 ]
Walker, Michael [1 ]
Delaney, William [3 ]
Zhong, Min [1 ]
机构：
[1] Assembly Biosci, San Francisco, CA USA
[2] Assembly Biosci, Discovery Biol, San Francisco, CA USA
[3] Assembly Biosci Inc, San Francisco, CA USA
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1132
引用
收藏
页码：S259 / S259
页数：1
相关论文
共 50 条
  • [41] Bleomycin is a potent small molecule inhibitor of hepatitis C virus replication
    Rakic, Bojana
    Brulotte, Marc
    Pezacki, John Paul
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232 : 856 - 856
  • [42] PRECLINICAL STUDIES ON MYRCLUDEX B, A NOVEL ENTRY INHIBITOR FOR HEPATITS B- AND HEPATITIS DELTA VIRUS (HDV) INFECTIONS
    Urban, S.
    Schulze, A.
    Schieck, A.
    Gaehler, C.
    Ni, Y.
    Meier, A.
    Alexandrov, A.
    Mier, W.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S5 - S5
  • [43] NOVEL SMALL-MOLECULE HCV-ENTRY INHIBITORS BLOCK VIRUS SPREAD AND PROMOTE VIRUS CLEARANCE IN VITRO
    de Muys, Jean-Marc
    Coburn, Glen
    Han, Amy O.
    Murga, Jose D.
    Fisch, Danielle
    Paul, Dorothy
    Moorji, Sameer
    Provoncha, Kathleen
    Qian, Dapeng
    Maddon, Paul J.
    Olson, William C.
    [J]. HEPATOLOGY, 2010, 52 (04) : 828A - 829A
  • [44] Novel Small Molecule Inhibitors of Dengue Virus Replication
    Byrd, Chelsea
    Page, Jessica
    Harver, Chris
    Grosenbach, Doug
    Berhanu, Aklile
    Hruby, Dennis
    Jordan, Robert
    [J]. ANTIVIRAL RESEARCH, 2009, 82 (02) : A38 - A38
  • [45] A New Class of Hepatitis B and D Virus Entry Inhibitors, Proanthocyanidin and Its Analogs, That Directly Act on the Viral Large Surface Proteins
    Tsukuda, Senko
    Watashi, Koichi
    Hojima, Taichi
    Isogawa, Masanori
    Iwamoto, Masashi
    Omagari, Katsumi
    Suzuki, Ryosuke
    Aizaki, Hideki
    Kojima, Soichi
    Sugiyama, Masaya
    Saito, Akiko
    Tanaka, Yasuhito
    Mizokami, Masashi
    Sureau, Camille
    Wakita, Takaji
    [J]. HEPATOLOGY, 2017, 65 (04) : 1104 - 1116
  • [46] Novel hepatitis C virus entry inhibitors, part 1: The discovery and optimization of 2,4,6-substituted triazines as potent HCV entry inhibitors
    Pendri, Annapurna
    Zhai, Weixu
    Li, Guo
    Wang, Tao
    Zhang, Zhongxing
    Yin, Zhiwei
    Han, Ying
    McClure, Andrea
    Allard, Christopher
    Wang, Ying-Kai
    Baldick, Carl J.
    Walsh, Ann W.
    Pokornowski, Kevin A.
    Cockett, Mark I.
    Tenney, Daniel J.
    Scola, Paul
    Poss, Michael A.
    Meanwell, Nicholas A.
    Gerritz, Samuel W.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [47] Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue Tropism
    Watashi, Koichi
    Wakita, Takaji
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2015, 5 (08): : 1 - 10
  • [48] Inhibitors of hepatitis C virus entry may be potent ingredients of optimal drug combinations
    Padmanabhan, Pranesh
    Dixit, Narendra M.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (23) : E4524 - E4526
  • [49] Discovery of Highly Potent Small Molecule Pan-Coronavirus Fusion Inhibitors
    Curreli, Francesca
    Chau, Kent
    Tran, Thanh-Thuy
    Nicolau, Isabella
    Ahmed, Shahad
    Das, Pujita
    Hillyer, Christopher D.
    Premenko-Lanier, Mary
    Debnath, Asim K.
    [J]. VIRUSES-BASEL, 2023, 15 (04):
  • [50] A Novel Class of Small Molecule Inhibitors of Hsp90
    Yi, Fang
    Regan, Lynne
    [J]. ACS CHEMICAL BIOLOGY, 2008, 3 (10) : 645 - 654
12345